Who
Jeffrey B. Mirviss
Director
Company insider
Files Form 4 as: Director, Conmed; EVP&Pres, Periph Intervent, Boston Scientific.
In numbers
- Trades disclosed
- 388
- Buys
- 0
- Sells
- 50
- Bought
- $0
- Sold
- $32.2M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 12 Feb 2013
- Last trade
- 1 Jul 2026
- Last filed
- 2 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 2 Jul 2026 | CNMD Conmedoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,603 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | CNMD Conmedoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,603 at $0.00 | filing |
| 25 Feb 2025filed 25 Feb 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Sold | $280K2,688 at $104.00 | filing |
| 24 Feb 2025filed 25 Feb 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Sold | $487K4,675 at $104.25 | filing |
| 19 Feb 2025filed 19 Feb 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Sold | $159K1,510 at $105.35 | filing |
| 17 Feb 2025filed 18 Feb 2025 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,334 at $0.00 | filing |
| 17 Feb 2025filed 18 Feb 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | —3,334 at $0.00 | filing |
| 17 Feb 2025filed 18 Feb 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code F | $161K1,521 at $106.11 | filing |
| 16 Feb 2025filed 18 Feb 2025 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,970 at $0.00 | filing |
| 16 Feb 2025filed 18 Feb 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | —2,970 at $0.00 | filing |
| 16 Feb 2025filed 18 Feb 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code F | $144K1,355 at $106.11 | filing |
| 14 Feb 2025filed 18 Feb 2025 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,776 at $0.00 | filing |
| 14 Feb 2025filed 18 Feb 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | —2,776 at $0.00 | filing |
| 14 Feb 2025filed 18 Feb 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code F | $134K1,266 at $106.11 | filing |
| 13 Feb 2025filed 18 Feb 2025 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,181 at $0.00 | filing |
| 13 Feb 2025filed 18 Feb 2025 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code A | —13,334 at $0.00 | filing |
| 12 Feb 2025filed 14 Feb 2025 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,115 at $0.00 | filing |
| 12 Feb 2025filed 14 Feb 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | —2,115 at $0.00 | filing |
| 12 Feb 2025filed 14 Feb 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code F | $92K868 at $105.77 | filing |
| 12 Feb 2025filed 13 Feb 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Sold | $1.4M13,022 at $105.06 | filing |
News
Boston Scientific Corporation $BSX Stock: Goelzer Investment Management Inc. Raises PositionBSX · dailypolitical.com · 17 Oct 2026Boston Scientific (NYSE:BSX) Upgraded at BarclaysBSX · dailypolitical.com · 10 Oct 2026Financial Contrast: Sysmex (OTCMKTS:SSMXY) and Boston Scientific (NYSE:BSX)BSX · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Jeffrey B. Mirviss; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.